As the FDA moves to speed early-stage clinical trials, former commissioners split on whether the public will see a reform or ...
Third positive data readout for the extended-release minoxidil positions drug for filing in male pattern hair loss, with ...
Office of Dietary Supplement Programs announces availability of “New Dietary Ingredient (NDI) Notifications and Related ...
What's happening, why it matters and what's next at FDA. This edition explores the agency's approval of Alcon's Brytly ...
AdvaMed CEO Scott Whitaker listed tariffs, user fees, reimbursement predictability and strengthening cybersecurity as his top ...
Dr. Squatch’s proposed $9m settlement over ‘natural’ claims and Sol de Janeiro’s trade dress dispute with MCoBeauty offer two ...
Proposals for a regulatory sandbox system in Brazil were informed by experiences in other countries, and a pilot involving ...
Chief global commercialization officer Anthony Mancini talked to Scrip about why the company is building a commercial ...
Fractyl’s Revita met the six-month co-primary endpoint in the 308-patient REMAIN-1 pivotal study, and a De Novo request is ...
Medicines For Europe has suggested that the Netherlands’ proposal to transpose the Urban Waste Water Treatment Directive ...
The UK agency confirms an AI center, early access scheme and PCCPs in a push for more adaptive regulation – but industry ...
Udall meeting to press drug developers to incorporate patient input throughout the product lifecycle, a core principle of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results